Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)

Yu Ching Wen; Van Thi Ngoc Tram; Wei Hao Chen; Chien Hsiu Li; Hsiu Lien Yeh; Phan Vu Thuy Dung; Kuo Ching Jiang; Han Ru Li; Jiaoti Huang; Michael Hsiao; Wei Yu Chen; Yen Nien Liu

doi:10.1038/s41419-023-06363-1

Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)

Yu Ching Wen
, Van Thi Ngoc Tram
, Wei Hao Chen
, Chien Hsiu Li
, Hsiu Lien Yeh
, Phan Vu Thuy Dung
, Kuo Ching Jiang
, Han Ru Li
, Jiaoti Huang
, Michael Hsiao
, Wei Yu Chen
, Yen Nien Liu

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Abstract

Correction to: Cell Death and Disease, published online 04 May 2023 In this article, the author Yen-Nien Liu has been affiliated with: ⁴International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan ¹⁰TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. it should read: ⁵Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. ¹⁰TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. The original article has been corrected.

Original language	English
Article number	92
Journal	Cell Death and Disease
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/s41419-023-06363-1
Publication status	Published - Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Immunology
Cellular and Molecular Neuroscience
Cell Biology
Cancer Research

Access to Document

10.1038/s41419-023-06363-1

Fingerprint

Dive into the research topics of 'Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)'. Together they form a unique fingerprint.

Cite this

Wen, Y. C., Tram, V. T. N., Chen, W. H., Li, C. H., Yeh, H. L., Thuy Dung, P. V., Jiang, K. C., Li, H. R., Huang, J., Hsiao, M., Chen, W. Y., & Liu, Y. N. (2024). Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7). Cell Death and Disease, 15(1), Article 92. https://doi.org/10.1038/s41419-023-06363-1

Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7). / Wen, Yu Ching; Tram, Van Thi Ngoc; Chen, Wei Hao et al.
In: Cell Death and Disease, Vol. 15, No. 1, 92, 01.2024.

Research output: Contribution to journal › Comment/debate › peer-review

Wen, YC, Tram, VTN, Chen, WH, Li, CH, Yeh, HL, Thuy Dung, PV, Jiang, KC, Li, HR, Huang, J, Hsiao, M, Chen, WY & Liu, YN 2024, 'Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)', Cell Death and Disease, vol. 15, no. 1, 92. https://doi.org/10.1038/s41419-023-06363-1

@article{938ae9cd59604611b6595fe004b64078,

title = "Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death \& Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)",

abstract = "Correction to: Cell Death and Disease, published online 04 May 2023 In this article, the author Yen-Nien Liu has been affiliated with: 4International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. it should read: 5Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. The original article has been corrected.",

author = "Wen, \{Yu Ching\} and Tram, \{Van Thi Ngoc\} and Chen, \{Wei Hao\} and Li, \{Chien Hsiu\} and Yeh, \{Hsiu Lien\} and \{Thuy Dung\}, \{Phan Vu\} and Jiang, \{Kuo Ching\} and Li, \{Han Ru\} and Jiaoti Huang and Michael Hsiao and Chen, \{Wei Yu\} and Liu, \{Yen Nien\}",

note = "Publisher Copyright: {\textcopyright} 2024, The Author(s).",

year = "2024",

month = jan,

doi = "10.1038/s41419-023-06363-1",

language = "English",

volume = "15",

journal = "Cell Death and Disease",

issn = "2041-4889",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)

AU - Wen, Yu Ching

AU - Tram, Van Thi Ngoc

AU - Chen, Wei Hao

AU - Li, Chien Hsiu

AU - Yeh, Hsiu Lien

AU - Thuy Dung, Phan Vu

AU - Jiang, Kuo Ching

AU - Li, Han Ru

AU - Huang, Jiaoti

AU - Hsiao, Michael

AU - Chen, Wei Yu

AU - Liu, Yen Nien

PY - 2024/1

Y1 - 2024/1

N2 - Correction to: Cell Death and Disease, published online 04 May 2023 In this article, the author Yen-Nien Liu has been affiliated with: 4International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. it should read: 5Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. The original article has been corrected.

AB - Correction to: Cell Death and Disease, published online 04 May 2023 In this article, the author Yen-Nien Liu has been affiliated with: 4International PhD Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. it should read: 5Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. 10TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/85183396446

UR - https://www.scopus.com/pages/publications/85183396446#tab=citedBy

U2 - 10.1038/s41419-023-06363-1

DO - 10.1038/s41419-023-06363-1

M3 - Comment/debate

C2 - 38287005

AN - SCOPUS:85183396446

SN - 2041-4889

VL - 15

JO - Cell Death and Disease

JF - Cell Death and Disease

IS - 1

M1 - 92

ER -

Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer (Cell Death & Disease, (2023), 14, 5, (304), 10.1038/s41419-023-05836-7)

Abstract

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this